Clinical trial
Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application
NCT00490230 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00490230 |
|---|---|
| Title | Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application |
| Official title | Assessment of Cutaneous Leishmaniasis Scar (Caused by Leishmania Major) for Cosmetic Outcome After Treatment With WR279396 (Paromomycin/Gentamicin Cream in Vehicle) Versus a No Treatment Control Group (Natural Healing) |
| Acronym | SCAR |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | Institut Pasteur Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis, Scar |
| Intervention type | Drug |
| Interventions | WR 279396 |
| Enrollment | 108 |
| Start date | Apr 1, 2007 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jun 22, 2007 |
| Last update posted | Jan 1, 2016 |
| Countries | Tunisia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: